1801338-22-6
Chemical Structure
AB-FUBICA
- CAS No.: 1801338-22-6
- Formula:C21H22FN3O2
- Molecular Weight:367.42
IUPAC Name: (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide
InChIKey: KTVPQJSKKGZIEA-IBGZPJMESA-N
SMILES: CC(C)[C@@H](C(N)=O)NC(C1=CN(CC2=CC=C(C=C2)F)C3=CC=CC=C13)=O
Biological Activity: AB-FUBICA (Compound 13) is a CB1 and CB2 receptor agonist that activates G-protein coupled inwardly rectifying potassium channels (GIRK) by binding to CB1 and CB2 receptors, displaying notable cannabinoid-like activity. AB-FUBICA has EC50 values of 21 nM for CB1 and 15 nM for CB2. AB-FUBICA may be suitable for studying pain management, neurodegenerative diseases, and inflammation-related mechanisms[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AB-FUBICA | AB-FUBICA (Compound 13) is a CB1 and CB2 receptor agonist that activates G-protein coupled inwardly rectifying potassium channels (GIRK) by binding to CB1 and CB2 receptors, displaying notable cannabinoid-like activity. AB-FUBICA has EC50 values of 21 nM for CB1 and 15 nM for CB2. AB-FUBICA may be suitable for studying pain management, neurodegenerative diseases, and inflammation-related mechanisms. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
